Oxford University : Will Resume AstraZeneca Vaccine Trials

According to the latest news from CNN, Oxford University issued a statement today stating that the clinical trial of the new coronavirus vaccine at Oxford University will resume after the trial was suspended due to a volunteer with unexplained symptoms.

The university is working with pharmaceutical giant AstraZeneca. The statement did not specify on which day the trial will resume.

The University of Oxford said, 'As part of the trial, about 18,000 people worldwide received the research vaccine. In such a large trial, some participants are expected to experience discomfort. We must carefully evaluate each case to ensure safety.'